Clinical Outcome of Retinal Vasculitis and Predictors for Prognosis of Ischemic Retinal Vasculitis

Sharief, Lazha; Lightman, Sue; Blum-Hareuveni, Tamar; Bar, Asaf; Tomkins-Netzer, Oren

doi:10.1016/j.ajo.2017.02.028

Cited by 28 publications

(20 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Other diseases that can be associated with retinal vasculitis are Bechet's, Sarcoidosis, Multiple Sclerosis, Collagen-vascular disease, Sympathetic Ophthalmia, and others. 2,5,12,13 Retinal vasculitis can also be a part of posterior uveitis, where this disease is found in 6-15% of patients with posterior uveitis. Our study found that the history of TORCH infection was the most frequent systemic disease compare to other diseases.…”

Section: Discussionmentioning

confidence: 99%

“…4 Another study conducted by Sarief L, et al found that retinal vasculitis was found in 6-15% of uveitis patients. 5 The findings seen on funduscopic examination are usually from venous sheathing to vascular damage that affects the permeability of blood vessel walls. This results in leakage of blood into the retinal extracellular space and cystoid macular edema.…”

Section: Introductionmentioning

confidence: 99%

“…In addition, neovascularization can cause recurrent vitreous hemorrhage and ultimately results in retinal detachment, rubeosis iridis, and neovaskular glaucoma, which can cause vision loss. 5 The prognosis of patients with retinal vasculitis varies greatly, and is determined by the underlying disease, degree of inflammation, and location of the affected retinal blood vessels. 1 Complication that can occur in patients with retinal vasculitis are quite severe.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Clinical Features and Factors Affecting the Success of Retinal Vasculitis Therapy

Zaini

Kartasasmita

2020

IJRetina

View full text Add to dashboard Cite

Introduction: Retinal vasculitis is an inflammatory eye condition that threatens vision. Inflammation occurs in the branches of retinal arteries, cause by primary ocular diseases or associated with other diseases. This study aims to describe clinical features and factors affecting therapeutic success in 52 patients with retinal vasculitis. Methods: This study was conducted using retrospective cohort in Retina Clinic of Cicendo Eye Hospital for vasculitis patients from January 1st- December 31st 2017. Data were collected retrospectively from the ophthalmic records of 52 patients (74 affected eyes). Descriptive analysis was performed on all data, chi-square and eksak fisher test were used to analyze risk factor and factors affecting the success of therapy. Result: Out of 529 vasculitis and vitreous hemorrhage cases, retinal vasculitis was found in 52 patients (9.8%). Mean age of retinal vasculitis patients were 42.3 years (range: 13-74 years). 35 patients (62.3%) were men and 22 patients (42.3%) had bilateral retinal vasculitis. Most patients (73%) had positive results for history of TORCH infections, and 23.76 % for tuberculosis. At initial presentation, almost all patients (93.2%) came with chief complaint of blurry vision, 42 patients (56.8%) came with baseline visual acuity £20/200. Vitreous hemorrhage was identified from retinal examination in 43 patients (58.1%). Therapeutic success was found better in patients with systemic involvement (74,1%). Conclusion: Despite limitation of facility in our hospital, therapeutic success rate of retinal vasculitis patients was quite good. Better laboratory investigation and other supporting examinations are still needed to obtain good therapeutic results and to conduct further study about the disease. Tuberculosis, TORCH, and autoimmune test are important examination when managing retinal vasculitis.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Clinical Features and Factors Affecting the Success of Retinal Vasculitis Therapy

Zaini

Kartasasmita

2020

IJRetina

View full text Add to dashboard Cite

show abstract

“…In other middle-income countries, like India, a report showed that the incidence of infants > 1500 g treated for threshold ROP with cryotherapy was 15.3% [15]. And in Lithuania, 54% of the infants needing treatment for ROP were > 1500 g at birth [16]. …”

Section: Discussionmentioning

confidence: 99%

Retinopathy of prematurity: incidence report of outliers based on international screening guidelines

et al. 2019

View full text Add to dashboard Cite

AimThe objective of this study is to report the incidence of retinopathy of prematurity (ROP) outliers that fall outside the screening guidelines of the American Academy of Ophthalmology (AAO) in our country.MethodsA retrospective review of 503 records of newborns evaluated in our institution between January 2011 and March 2017. We analyzed the data by subgroups based on gestational age (GA), birth weight (BW) and stage, focusing on the outliers that don’t meet the criteria of the screening AAO guidelines (GA ≤ 30 weeks, BW ≤ 1500 g).ResultsOf the 503 records, 352 had some degree of ROP, 91.76% being bilateral, and 26.2% require treatment. The mean GA at delivery was 30.56 ± 2.33 weeks, and the mean BW was 1287.90 ± 338.52 g. For the current AAO/AAP ROP screening, 19.9% were outliers, of which (57%) had ROP diagnosis and (38%) required treatment.ConclusionsROP diagnosis in newborns of BW > 1500 g or GA > 30 weeks is not uncommon in Mexico, and it is important to take this into account to adjust the selection criteria on each population to reach all the infants at risk.

show abstract

“…Диагностически значимым также считается капиллярное просачивание в различных отделах сетчатки в сочетании с ликеджем в области ДЗН (так называемый «горячий» ДЗН), возникающим из расширенных капилляров вследствие первичной инфильтрации ДЗН или вторичных сосудистых изменений на фоне воспаления. При окклюзирующих формах нейроретиноваскулита возможны увеличение времени артериовенозного транзита, венозной перфузии, пульсирующий характер кровотока и выявление зон отсутствия капиллярной перфузии на периферии сетчатки [71].…”

Section: этиология и патогенез нейроретиноваскулита с вторичной окклюunclassified

The main aspects of retinal vein occlusion etiopathogenisis in young adults. Part I. Neuroretinovasculitis (prothrombotic potential, clinical manifestations)

Тульцева

Николаевна²,

Lisochkina

et al. 2018

Ophthalmology Reports

View full text Add to dashboard Cite

This review is dedicated to the neuroretinovasculitis, which is the leading cause of retinal vein occlusion in young adults. Presumed etiological factors, possible pathogenic mechanisms, and clinical manifestation are analyzed. Advisability of multidisciplinary approach in management and individual approach in treatment of patients with neuroretinovasculitis with secondary retinal vein occlusion are justified.

show abstract

Clinical Outcome of Retinal Vasculitis and Predictors for Prognosis of Ischemic Retinal Vasculitis

Abstract: Retinal vasculitis is associated with an increased risk of vision loss, mainly secondary to macular ischemia, and has a higher risk of macular edema compared to eyes with no vasculitis. Ischemia involving ≥2 quadrants is a risk factor for new vessel formation.

Cited by 28 publications

References 19 publications

Clinical Features and Factors Affecting the Success of Retinal Vasculitis Therapy

Clinical Features and Factors Affecting the Success of Retinal Vasculitis Therapy

Retinopathy of prematurity: incidence report of outliers based on international screening guidelines

The main aspects of retinal vein occlusion etiopathogenisis in young adults. Part I. Neuroretinovasculitis (prothrombotic potential, clinical manifestations)

Contact Info

Product

Resources

About